Macrophage escape by cholesterol-polyoxyethylene sorbitol oleate micelles for pulmonary delivery

Nanomedicine (Lond). 2020 Feb;15(5):489-509. doi: 10.2217/nnm-2019-0376. Epub 2020 Feb 20.

Abstract

Aim: Micelles are one of the most promising nanoplatforms for drug delivery, and here, cholesterol-conjugated polyoxyethylene sorbitol oleate (CPSO) micelles have been fabricated for the pulmonary delivery of paclitaxel (PTX). Materials & methods: PTX-CPSO micelles were prepared by a dialysis-ultrasonic method, and a single-factor experiment with a Box-Behnken design was conducted to optimize the formulation. Furthermore, intracellular and phagocytosis escape studies of the optimized formulation were performed on A549 and NR8383 cells. Results: The optimal micelles exhibited satisfactory encapsulation efficiency (78.48 ± 2.36%) and drug loading (17.06 ± 1.71%). In vitro studies showed enhanced CPSO micelle A549 cellular uptake and their ability to escape macrophages. Conclusion: PTX-CPSO micelles could be a promising system for pulmonary targeting by intravenous administration.

Keywords: Box–Behnken design; CPSO; cholesterol-conjugated polyoxyethylene sorbitol oleate; drug loading; encapsulation efficiency; intracellular delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Cholesterol
  • Drug Carriers*
  • Humans
  • Lung
  • Macrophages*
  • Micelles*
  • Oleic Acid
  • Paclitaxel / administration & dosage*
  • Particle Size
  • Polyethylene Glycols
  • Sorbitol

Substances

  • Drug Carriers
  • Micelles
  • Oleic Acid
  • Polyethylene Glycols
  • Sorbitol
  • Cholesterol
  • Paclitaxel